We are live on ! Find out more
AI

Atom Investors Portfolio holdings

AUM $1.4B
1-Year Est. Return 23.77%
This Fund
S&P 500
This Quarter Est. Return
+9.44%
1 Year Est. Return
+23.77%
3 Year Est. Return
+63.44%
5 Year Est. Return
+52.26%
10 Year Est. Return
AUM
$802M
AUM Growth
+$235M
Cap. Flow
+$185M
Cap. Flow %
23.02%
Top 10 Hldgs %
11.97%
Holding
695
New
256
Increased
183
Reduced
117
Closed
131

Top Sells

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$5.92M
2
TEL icon
TE Connectivity
TEL
+$4.47M
3
WM icon
Waste Management
WM
+$4.17M
4
FLO icon
Flowers Foods
FLO
+$3.8M
5
CLS icon
Celestica
CLS
+$3.63M

Sector Composition

Rank Sector Weight
1 Healthcare 15.53%
2 Technology 14.37%
3 Industrials 12.11%
4 Financials 11.82%
5 Consumer Discretionary 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
126
McKesson
MCK
$100B
$2.06M 0.26%
3,837
+1,774
+86% +$901K
XLY icon
127
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.6B
$2.06M 0.26%
22,400
+2,400
+12% +$214K
MRVL icon
128
Marvell Technology
MRVL
$168B
$2.04M 0.25%
+28,757
New +$1.97M
PGR icon
129
Progressive
PGR
$123B
$2M 0.25%
9,690
-5,948
-38% -$1.1M
DOLE icon
130
Dole
DOLE
$1.35B
$2M 0.25%
167,430
+25,791
+18% +$299K
WMT icon
131
Walmart Inc
WMT
$885B
$1.99M 0.25%
+33,105
New +$1.89M
OC icon
132
Owens Corning
OC
$11.2B
$1.98M 0.25%
11,878
+10,423
+716% +$1.59M
PSTX
133
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1.98M 0.25%
619,674
+264,058
+74% +$880K
MRSN
134
DELISTED
Mersana Therapeutics
MRSN
$1.97M 0.25%
17,569
-13,417
-43% -$1.33M
META icon
135
Meta Platforms (Facebook)
META
$1.42T
$1.96M 0.24%
4,033
-710
-15% -$317K
WTTR icon
136
Select Water Solutions
WTTR
$2.3B
$1.96M 0.24%
211,938
-15,081
-7% -$122K
QQQ icon
137
Invesco QQQ Trust
QQQ
$453B
$1.95M 0.24%
+4,393
New +$1.88M
LUV icon
138
Southwest Airlines
LUV
$22B
$1.94M 0.24%
+66,496
New +$2.06M
BRO icon
139
Brown & Brown
BRO
$23.6B
$1.93M 0.24%
22,042
+6,585
+43% +$529K
WAL icon
140
Western Alliance Bancorporation
WAL
$8.79B
$1.92M 0.24%
29,957
+16,987
+131% +$1.04M
GS icon
141
Goldman Sachs
GS
$300B
$1.91M 0.24%
4,579
+911
+25% +$354K
EVRI
142
DELISTED
Everi Holdings
EVRI
$1.91M 0.24%
189,630
+124,691
+192% +$1.29M
CLDX icon
143
Celldex Therapeutics
CLDX
$2.99B
$1.89M 0.24%
45,140
+4,258
+10% +$175K
THC icon
144
Tenet Healthcare
THC
$20.5B
$1.89M 0.24%
17,973
-7,031
-28% -$632K
ON icon
145
ON Semiconductor
ON
$31.8B
$1.89M 0.24%
25,678
+4,813
+23% +$368K
MET icon
146
MetLife
MET
$61.9B
$1.87M 0.23%
25,230
+6,116
+32% +$426K
ELAN icon
147
Elanco Animal Health
ELAN
$13.2B
$1.87M 0.23%
+114,825
New +$1.8M
PECO icon
148
Phillips Edison & Co
PECO
$5.46B
$1.86M 0.23%
51,794
+16,173
+45% +$572K
NOA
149
North American Construction
NOA
$369M
$1.85M 0.23%
+83,082
New +$1.93M
HCA icon
150
HCA Healthcare
HCA
$87.2B
$1.83M 0.23%
5,478
-1,005
-16% -$307K

Similar funds

Atom Investors's Q1 2024 Portfolio in Review

As of Q1 2024, Atom Investors held 695 positions worth $802M, up 42% from $566M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Atom Investors deployed $185M of net new capital in Q1 2024, opening 256 new positions and adding to 183 existing holdings. Its largest new stake was Regency Centers: 138,608 shares worth $8.39M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Ecolab, an estimated $5.92M trimmed.

  • Atom Investors's largest Q1 2024 buy was Regency Centers: 138,608 shares worth $8.39M.
  • Atom Investors added most to State Street SPDR S&P Biotech ETF in Q1 2024, an estimated $5.98M increase.
  • Atom Investors's biggest Q1 2024 reduction was Ecolab, cutting an estimated $5.92M.
  • Atom Investors fully exited Flowers Foods in Q1 2024, selling an estimated $3.8M.
  • Atom Investors's ten largest holdings make up 12% of its $802M portfolio in Q1 2024.
  • Atom Investors opened 256 new positions and closed 131 in Q1 2024.
  • Atom Investors's portfolio value rose 42% quarter-over-quarter to $802M.

Based on Atom Investors's 13F filing for Q1 2024, filed 15 May 2024.